O'Farrell Elizabeth G. — SEC insider filings

SEC reporting owner CIK 1744662. 24 insider filings on record with FilingPulse; latest filed 2026-11-19.

Transaction summary — filings shown

Covers all 24 filings on record, filed 2020-08-24 to 2026-11-19. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
PDL BIOPHARMA, INC. (PDLI)Director3—2 legs · 89,117 sh · $213,7112
LENSAR, Inc. (LNSR)Director9—2 legs · 33,175 sh · $169,98914
GERON CORP (GERN)Director83 legs · 30,627 sh · $60,237—6
Inhibikase Therapeutics, Inc. (IKT)Director3——3
SpyGlass Pharma, Inc. (SGP)Director1——1

Insider filings — O'Farrell Elizabeth G.

FiledFormIssuerReported transactionsSource
2026-11-194LENSAR, Inc. (LNSR)Option exercise (M): 22,214 @ $3.23 · Sale (S): 22,214 @ $5.20 · Option exercise (M): 10,961 @ $3.23 · Sale (S): 10,961 @ $4.97 · Option exercise (M): 22,214 (derivative) @ $0 · Option exercise (M): 10,961 (derivative) @ $0EDGAR
2026-06-054LENSAR, Inc. (LNSR)Grant/award (A): 17,421 @ $0EDGAR
2026-05-264GERON CORP (GERN)Grant/award (A): 220,000 (derivative) @ $0EDGAR
2026-02-094SpyGlass Pharma, Inc. (SGP)Grant/award (A): 13,700 (derivative) @ $0EDGAR
2025-05-284LENSAR, Inc. (LNSR)Grant/award (A): 7,374 @ $0EDGAR
2025-05-224GERON CORP (GERN)Grant/award (A): 180,000 (derivative) @ $0EDGAR
2024-05-104GERON CORP (GERN)Grant/award (A): 180,000 (derivative) @ $0EDGAR
2024-05-094LENSAR, Inc. (LNSR)Grant/award (A): 22,000 @ $0EDGAR
2023-08-244GERON CORP (GERN)Purchase (P): 6,607 @ $2.28 · Purchase (P): 6,579 @ $2.28EDGAR
2023-06-024GERON CORP (GERN)Grant/award (A): 125,000 (derivative) @ $0EDGAR
2023-05-304LENSAR, Inc. (LNSR)Grant/award (A): 9,288 @ $0 · Grant/award (A): 33,175 (derivative) @ $0EDGAR
2022-06-284Inhibikase Therapeutics, Inc. (IKT)Grant/award (A): 40,000 (derivative) @ $0EDGAR
2022-05-274LENSAR, Inc. (LNSR)Grant/award (A): 4,285 @ $0 · Grant/award (A): 15,616 (derivative) @ $0EDGAR
2022-05-114GERON CORP (GERN)Grant/award (A): 125,000 (derivative) @ $0EDGAR
2021-06-294Inhibikase Therapeutics, Inc. (IKT)Grant/award (A): 22,677 (derivative) @ $0EDGAR
2021-05-204LENSAR, Inc. (LNSR)Grant/award (A): 20,847 (derivative) @ $0EDGAR
2021-05-134GERON CORP (GERN)Grant/award (A): 83,000 (derivative) @ $0EDGAR
2021-03-164LENSAR, Inc. (LNSR)Grant/award (A): 13,445 (derivative) @ $0EDGAR
2021-02-024LENSAR, Inc. (LNSR)Grant/award (A): 28,249 (derivative) @ $0EDGAR
2020-12-294Inhibikase Therapeutics, Inc. (IKT)Grant/award (A): 6,825 (derivative) @ $0EDGAR
2020-11-244PDL BIOPHARMA, INC. (PDLI)Sale (S): 25,826 @ $2.44EDGAR
2020-11-204PDL BIOPHARMA, INC. (PDLI)Sale (S): 63,291 @ $2.38EDGAR
2020-08-244PDL BIOPHARMA, INC. (PDLI)Grant/award (A): 25,826 @ $0 · Grant/award (A): 118,671 (derivative) @ $3.63EDGAR
2020-08-244GERON CORP (GERN)Purchase (P): 17,441 @ $1.73EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-18 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1744662 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs